Harlan S. Robins, Chief Scientific Officer at Adaptive Biotechnologies Corp (ADPT), sold 492,400 shares at $21.72 ($10.8M) on 2026-07-21, disclosed to the SEC on 2026-07-23.
Scheduled sale ($10.8M) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.72 | 278,698 | $6.1M | 56.2% |
| 2 | $22.12 | 213,702 | $4.7M | 43.8% |
| Total | $21.89 avg | 492,400 | $10.8M | 100% |
| Filing → |
| ADPT | SELL | 2026-04-10 | $149K | — | Filing → |
| ADPT | SELL | 2026-03-13 | $6.2M | — | Filing → |
| ADPT | SELL | 2026-03-04 | $392K | — | Filing → |